Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia

Report Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia”. It gives a robust idea about the patient recruitment status by geography, by sponsor company, and by year for all the major CNS indications. Furthermore, the report provides profiles of prevalence with forecast data up to 2017 for all the major CNS indications. The major indications covered in the report are Alzheimer’s disease, Parkinson’s disease, Epilepsy, Schizophrenia and Depression. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research found that the highest number of trials was conducted in schizophrenia, which corresponds to the highest levels of patient recruitment for the period 2000-2009, for trials which were industry sponsored with completed status. Within the CNS market, the Alzheimer’s and Parkinson’s disease sectors have been identified as the fastest growing sectors. In terms of reimbursement, countries like Germany, France and Canada have been identified as having the most robust and patient-friendly regulations for CNS therapeutics. The central nervous system is a complex and sophisticated system that regulates and co-ordinates the basic functions and activities of the human body. The human central nervous system consists of the brain, spinal cord and the neural network connecting these to the body. Owing to its complexity and intricacies, the CNS is vulnerable to various complications and disorders. Disorders within the CNS are primarily associated with the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system and the neuromuscular network, including the muscles. A substantial portion of CNS disorders can be grouped under neurodegenerative disorders such as Alzheimer’s, which are primarily associated with the deterioration or break down of cerebral and spinal cells. Other diseases associated with the CNS include psychiatric or mental disorders such as Attention Deficit Hyperactivity Disorder (ADHD). These disorders are related to individuals’ psychological or behavioral patterns, and are thought to cause distress or disabilities that are not expected as part of normal development. Other major neurological disorders include epilepsy, pain and sleep related complications such as migraine and insomnia.

Scope

The report analyzes the clinical trial recruitment trends of the pharmaceutical companies for various neurology trials. Its scope includes - 

• Insight on Clinical Trials conducted for major indications of neurology such as Alzheimer’s disease, Parkinson’s disease, Epilepsy, Schizophrenia and Depression from 2000-2009.
• The status of patient recruitment by geography, Sponsor Company, year and stage of development.
• Analysis of the average number of patients recruited per trial for major indications per year.
• Analysis of the average number of patients recruited per trial for major indications by stage of development.
• The prevalence population in India, China and Brazil for all major indications from 2010-2017.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Identify and understand the status of clinical trials conducted for major neurology indications from 2000-2009.
• Build understanding of patient recruitment status by geography, Sponsor Company, year and stage of development.
• Identify the prevalence population for the major indications up to 2017.
• Identify the average number of patients recruited by stage of development and across years for all major indications.
• Identify the indication in which the highest number of trials is conducted and the highest number of patients recruited.

Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 9

2 Clinical Trial Recruitment in Central Nervous System Disorders - Introduction 12
2.1 GBI Research Report Guidance 13

3 Clinical Trials Overview 14
3.1 Clinical Trials Share by Therapeutic Area 14
3.2 Clinical Trials by Pharmaceutical Companies, 2005-2010 21
3.3 Clinical Trials and Patient Recruitment in CNS 22

4 Clinical Trials and Patient Recruitment for Alzheimer’s Disease 24
4.1 Introduction 24
4.2 Clinical Trials for Alzheimer’s Disease 25
4.2.1 Number of Clinical Trials by Stage of Development 25
4.2.2 Number of Clinical Trials by Sponsor 26
4.2.3 Number of Clinical Trials by Geography 27
4.2.4 Number of Clinical Trials by Year 28
4.3 Prevalence Population for Alzheimer’s disease (2010-2017) 29
4.3.1 Brazil 29
4.3.2 India 30
4.3.3 China 31
4.4 Patient Recruitment for Alzheimer’s Disease 32
4.4.1 Number of Patients Recruited by Stage of Development 32
4.4.2 Number of Patients Recruited by Sponsor 33
4.4.3 Number of Patients Recruited by Geography 34
4.4.4 Number of Patients Recruited Per Year 35
4.5 Average Number of Patients Recruited Per Trial 36
4.5.1 Average Number of Patients Recruited Per Trial by Stage of Development 36
4.5.2 Average Number of Patients Recruited Per Trial Per Year 37

5 Clinical Trials and Patient Recruitment for Parkinson’s Disease 38
5.1 Introduction 38
5.2 Clinical Trials for Parkinson’s Disease 39
5.2.1 Number of Clinical Trials by Stage of Development 39
5.2.2 Number of Clinical Trials by Sponsor 40
5.2.3 Number of Clinical Trials by Geography 41
5.2.4 Number of Clinical Trials by Year 42
5.3 Prevalence Population for Parkinson’s disease (2010-2017) 43
5.3.1 Brazil 43
5.3.2 India 44
5.3.3 China 45
5.4 Patient Recruitment for Parkinson’s Disease 46
5.4.1 Number of Patients Recruited by Stage of Development 46
5.4.2 Number of Patients Recruited by Sponsor 47
5.4.3 Number of Patients Recruited by Geography 48
5.4.4 Number of Patients Recruited Per Year 49
5.5 Average Number of Patients Recruited Per Trial 50
5.5.1 Average Number of Patients Recruited Per Trial by Stage of Development 50
5.5.2 Average Number of Patients Reruited per Trial per Year 51

6 Clinical Trials and Patient Recruitment for Epilepsy 52
6.1 Introduction 52
6.2 Clinical Trials for Epilepsy 53
6.2.1 Number of Clinical Trials by Stage of Development 53
6.2.2 Number of Clinical Trials by Sponsor 54
6.2.3 Number of Clinical Trials by Geography 55
6.2.4 Number of Clinical Trials by Year 56
6.3 Prevalence Population for Epilepsy (2010-2017) 57
6.3.1 Brazil 57
6.3.2 India 58
6.3.3 China 59
6.4 Patient Recruitment for Epilepsy 60
6.4.1 Number of Patients Recruited by Stage of Development 60
6.4.2 Number of Patients Recruited by Sponsor 61
6.4.3 Number of Patients Recruited by Geography 62
6.4.4 Number of Patients Recruited Per Year 63
6.5 Average Number of Patients Recruited Per Trial 64
6.5.1 Average Number of Patients Recruited Per Trial by Stage of Development 64
6.5.2 Average Number of Patients Recruited Per Trial Per Year 65

7 Clinical Trials and Patient Recruitment for Schizophrenia 66
7.1 Introduction 66
7.2 Clinical Trials for Schizophrenia 67
7.2.1 Number of Clinical Trials by Stage of Development 67
7.2.2 Number of Clinical Trials by Sponsor 68
7.2.3 Number of Clinical Trials by Geography 69
7.2.4 Number of Clinical Trials by Year 70
7.3 Prevalence Population for Schizophrenia (2010-2017) 71
7.3.1 Brazil 71
7.3.2 India 72
7.3.3 China 73
7.4 Patient Recruitment for Schizophrenia 74
7.4.1 Number of Patients Recruited by Stage of Development 74
7.4.2 Number of Patients Recruited by Sponsor 75
7.4.3 Number of Patients Recruited by Geography 76
7.4.4 Number of Patients Recruited Per Year 77
7.5 Average Number of Patients Recruited Per Trial 78
7.5.1 Average Number of Patients Recruited Per Trial by Stage of Development 78
7.5.2 Average Number of Patients Recruited Per Trial Per Year 79

8 Clinical Trials and Patient Recruitment for Depression 80
8.1 Introduction 80
8.2 Clinical Trials for Depression 81
8.2.1 Number of Clinical Trials by Stage of Development 81
8.2.2 Number of Clinical Trials by Sponsor 82
8.2.3 Number of Clinical Trials by Geography 83
8.2.4 Number of Clinical Trials by Year 84
8.3 Prevalence Population for Depression (2010-2017) 85
8.3.1 Brazil 85
8.3.2 India 86
8.3.3 China 87
8.4 Patient Recruitment for Depression 88
8.4.1 Number of Patients Recruited by Stage of Development 88
8.4.2 Number of Patients Recruited by Sponsor 89
8.4.3 Number of Patients Recruited by Geography 90
8.4.4 Number of Patients Recruited Per Year 91
8.5 Average Number of Patients Recruited Per Trial 92
8.5.1 Average Number of Patients Recruited per Trial by Stage of Development 92
8.5.2 Average Number of Patients Recruited per Trial per Year 93

9 Clinical Trials Recruitment in Central Nervous System: Appendix 94
9.1 Market Definitions 94
9.2 Abbreviations 94
9.3 Research Methodology 94
9.3.1 Coverage 94
9.3.2 Secondary Research 95
9.3.3 Primary Research 95
9.3.4 Expert Panel Validation 95
9.3.5 Section-wise methodology 95
9.4 Contact Us 97
9.5 Disclaimer 97
9.6 Sources 97

1.1 List of Tables

Table 1: Clinical Trial Recruitment in CNS, Global, Ongoing Trials by Therapeutic Area, 2005-2010 14
Table2: Clinical Trial Recruitment in CNS, Asia, Ongoing Trials by Therapeutic Area, 2005-2010 15
Table3: Clinical Trial Recruitment in CNS, Europe, Ongoing Trials by Therapeutic Area, 2005-2010 16
Table4: Clinical Trial Recruitment in CNS, Middle East, Ongoing Trials by Therapeutic Area, 2005-2010 17
Table5: Clinical Trial Recruitment in CNS, South and Central America, Ongoing Trials by Therapeutic Area, 2005-2010 18
Table6: Clinical Trial Recruitment in CNS, North America, Ongoing Trials by Therapeutic Area, 2005-2010 19
Table7: Clinical Trial Recruitment in CNS, Rest of World, Ongoing Trials by Therapeutic Area, 2005-2010 20
Table8: Clinical Trial Recruitment in CNS, Global, Clinical Trials by Pharmaceutical Companies, 2005-2010 21
Table9: Clinical Trial Recruitment in CNS, Global, Clinical Trials in Major Indications, 2000-2009 22
Table10: Clinical Trial Recruitment in CNS, Global, Total Number of Patients Recruited for Major Indications, 2000-2009 23
Table 11: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials by Phase, 2000-2009 25
Table 12: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials by Sponsor, 2000-2009 26
Table 13: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials by Geography, (%), 2000-2009 27
Table 14: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials per Year, 2000-2009 28
Table 15: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Prevalence Population, Brazil, (million) 2010-2017 29
Table 16: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Prevalence Population, India, (Million) 2010-2017 30
Table 17: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Prevalence Population, China, (Million) 2010-2017 31
Table 18: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited by Phase, 2000-2009 32
Table 19: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited by Sponsor, 2000-2009 33
Table 20: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited by Geography, (%), 2000-2009 34
Table 21: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited per Year, 2000-2009 35
Table 22: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 36
Table 23: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009 37
Table 24: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials by Phase, 2000-2009 39
Table 25: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials by Sponsor, 2000-2009 40
Table 26: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials by Geography (%), 2000-2009 41
Table 27: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials per Year, 2000-2009 42
Table 28: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Prevalence Population, Brazil, (Million), 2010-2017 43
Table 29: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Prevalence Population, India, (Million), 2010-2017 44
Table 30: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Prevalence Population, China, (Million), 2010-2017 45
Table 31: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited by Phase, 2000-2009 46
Table 32: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited by Major Sponsors, 2000-2009 47
Table 33: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited by Geography (%), 2000-2009 48
Table 34: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited per Year, 2000-2009 49
Table 35: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Average Number of Patients Recruited by Stage of Development, 2000-2009 50
Table 36: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009 51
Table 37: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials by Phase, 2000-2009 53
Table 38: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials by Major Sponsors, 2000-2009 54
Table 39: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials by Geography (%), 2000-2009 55
Table 40: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials per Year, 2000-2009 56
Table 41: Clinical Trial Recruitment in CNS, Epilepsy, Prevalence Population, Brazil, (Million), 2010-2017 57
Table 42: Clinical Trial Recruitment in CNS, Epilepsy, Prevalence Population, India, (Million), 2010-2017 58
Table 43: Clinical Trial Recruitment in CNS, Epilepsy, Prevalence Population, China, (Million), 2010-2017 59
Table 44: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited by Phase, 2000-2009 60
Table 45: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited by Major Sponsors, 2000-2009 61
Table 46: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited by Geography (%), 2000-2009 62
Table 47: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited per Year, 2000-2009 63
Table 48: Clinical Trial Recruitment in CNS, Epilepsy, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 64
Table 49: Clinical Trial Recruitment in CNS, Epilepsy, Average Number of Patients Recruited per Trial per Year, 2000-2009 65
Table 50: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials by Phase, 2000-2009 67
Table 51: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials by Major Sponsors, 2000-2009 68
Table 52: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials by Geography (%), 2000-2009 69
Table 53: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials per Year, 2000-2009 70
Table 54: Clinical Trial Recruitment in CNS, Schizophrenia, Prevalence Population, Brazil, (Million), 2010-2017 71
Table 55: Clinical Trial Recruitment in CNS, Schizophrenia, Prevalence Population, India, (Million), 2010-2017 72
Table 56: Clinical Trial Recruitment in CNS, Schizophrenia, Prevalence Population, China, (Million), 2010-2017 73
Table  57: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited by Phase, 2000-2009 74
Table  58: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited by Major Sponsors, 2000-2009 75
Table  59: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited by Geography (%), 2000-2009 76
Table  60: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited per Year, 2000-2009 77
Table  61: Clinical Trial Recruitment in CNS, Schizophrenia, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 78
Table  62: Clinical Trial Recruitment in CNS, Schizophrenia, Average Number of Patients Recruited per Trial per Year, 2000-2009 79
Table  63: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials by Phase, 2000-2009 81
Table 64: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials by Major Sponsors, 2000-2009 82
Table 65: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials by Geography, (%), 2000-2009 83
Table 66: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials per Year, 2000-2009 84
Table 67: Clinical Trial Recruitment in CNS, Depression, Prevalence Population, Brazil, (Million), 2010-2017 85
Table 68: Clinical Trial Recruitment in CNS, Depression, Prevalence Population, India, (Million), 2010-2017 86
Table 69: Clinical Trial Recruitment in CNS, Depression, Prevalence Population, China, (Million), 2010-2017 87
Table 70: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Stage of Development, 2000-2009 88
Table 71: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Major Sponsors, 2000-2009 89
Table 72: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Geography, (%), 2000-2009 90
Table 73: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Major Sponsors, 2000–2009 91
Table 74: Clinical Trial Recruitment in CNS, Depression, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 92
Table 75: Clinical Trial Recruitment in CNS, Depression, Average Number of Patients Recruited per Trial per Year, 2000-2009 93

1.2 List of Figures

Figure 1: Clinical Trial Recruitment in CNS, Global, Ongoing Trials by Therapeutic Area, 2005-2010 14
Figure 2: Clinical Trial Recruitment in CNS, Asia, Ongoing Trials by Therapeutic Area, 2005-2010 15
Figure 3: Clinical Trial Recruitment in CNS, Europe, Ongoing Trials by Therapeutic Area, 2005-2010 16
Figure 4: Clinical Trial Recruitment in CNS, Middle East, Ongoing Trials by Therapeutic Area, 2005-2010 17
Figure 5: Clinical Trial Recruitment in CNS, South and Central America, Ongoing Trials by Therapeutic Area, 2005-2010 18
Figure 6: Clinical Trial Recruitment in CNS, North America, Ongoing Trials by Therapeutic Area, 2005-2010 19
Figure 7: Clinical Trial Recruitment in CNS, Rest of World, Ongoing Trials by Therapeutic Area, 2005-2010 20
Figure 8: Clinical Trial Recruitment in CNS, Global, Clinical Trials by Pharmaceutical Companies, 2005-2010 21
Figure 9: Clinical Trial Recruitment in CNS, Global, Clinical Trials in Major Indications, 2000-2009 22
Figure 10: Clinical Trial Recruitment in CNS, Global, Total Number of Patients Recruited for Major Indications, 2000-2009 23
Figure 11: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials by Phase, 2000-2009 25
Figure 12: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials by Major Sponsor, 2000-2009 26
Figure 13: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials by Geography, (%), 2000-2009 27
Figure 14: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Clinical Trials per Year, 2000-2009 28
Figure 15: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Prevalence Population, Brazil, (million), 2010-2017 29
Figure 16: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Prevalence Population, India, (Million) 2010-2017 30
Figure 17: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Prevalence Population, China, (Million) 2010-2017 31
Figure 18: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited by Phase, 2000-2009 32
Figure 19: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited by Major Sponsors, 2000-2009 33
Figure 20: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited by Geography, (%), 2000-2009 34
Figure 21: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Total Number of Patients Recruited per Year, 2000-2009 35
Figure 22: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 36
Figure 23: Clinical Trial Recruitment in CNS, Alzheimer’s Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009 37
Figure 24: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials by Phase, 2000-2009 39
Figure 25: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials by Sponsor, 2000-2009 40
Figure 26: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials by Geography, (%), 2000-2009 41
Figure 27: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Clinical Trials per Year, 2000-2009 42
Figure 28: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Prevalence Population, Brazil, (Million), 2010-2017 43
Figure 29: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Prevalence Population, India, (Million), 2010-2017 44
Figure 30: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Prevalence Population, China, (Million), 2010-2017 45
Figure 31: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited by Phase, 2000-2009 46
Figure 32: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited by Sponsor, 2000-2009 47
Figure 33: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited by Geography, (%), 2000-2009 48
Figure 34: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Total Number of Patients Recruited per Year, 2000-2009 49
Figure 35: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Average Number of Patients Recruited by Stage of Development, 2000-2009 50
Figure 36: Clinical Trial Recruitment in CNS, Parkinson’s Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009 51
Figure 37: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials by Phase, 2000-2009 53
Figure 38: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials by Major Sponsors, 2000-2009 54
Figure 39: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials by Geography, (%), 2000-2009 55
Figure 40: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Clinical Trials per Year, 2000-2009 56
Figure 41: Clinical Trial Recruitment in CNS, Epilepsy, Prevalence Population, Brazil, (Million), 2010-2017 57
Figure 42: Clinical Trial Recruitment in CNS, Epilepsy, Prevalence Population, India, (Million), 2010-2017 58
Figure 43: Clinical Trial Recruitment in CNS, Epilepsy, Prevalence Population, China, (Million), 2010-2017 59
Figure 44: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited by Phase, 2000-2009 60
Figure 45: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited by Major Sponsors, 2000-2009 61
Figure 46: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited by Geography , (%), 2000-2009 62
Figure 47: Clinical Trial Recruitment in CNS, Epilepsy, Total Number of Patients Recruited per Year, 2000-2009 63
Figure 48: Clinical Trial Recruitment in CNS, Epilepsy, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 64
Figure 49: Clinical Trial Recruitment in CNS, Epilepsy, Average Number of Patients Recruited per Trial per Year, 2000-2009 65
Figure 50: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials by Phase, 2000-2009 67
Figure 51: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials by Major Sponsors, 2000-2009 68
Figure 52: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials by Geography ,(%), 2000-2009 69
Figure 53: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Clinical Trials per Year, 2000-2009 70
Figure 54: Clinical Trial Recruitment in CNS, Schizophrenia, Prevalence Population, Brazil, (Million), 2010-2017 71
Figure 55: Clinical Trial Recruitment in CNS, Schizophrenia, Prevalence Population, India, (Million), 2010-2017 72
Figure 56: Clinical Trial Recruitment in CNS, Schizophrenia, Prevalence Population, China, (Million), 2010-2017 73
Figure 57: Clinical Trial Recruitment bfin CNS, Schizophrenia, Total Number of Patients Recruited by Phase, 2000-2009 74
Figure 58: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited by Major Sponsors, 2000-2009 75
Figure 59: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited by Geography , (%), 2000-2009 76
Figure 60: Clinical Trial Recruitment in CNS, Schizophrenia, Total Number of Patients Recruited per Year, 2000-2009 77
Figure 61: Clinical Trial Recruitment in CNS, Schizophrenia, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 78
Figure 62: Clinical Trial Recruitment in CNbfS, Schizophrenia, Average Number of Patients Recruited per Trial per Year, 2000-2009 79
Figure 63: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials by Phase, 2000-2009 81
Figure 64: Clinical Trial Recrbfuitment in CNS, Depression, Total Number of Clinical Trials by Major Sponsors, 2000-2009 82
Figure 65: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials by Geography, (%), 2000-2009 83
Figure 66: Clinical Trial Recruitment in CNS, Depression, Total Number of Clinical Trials per Year, 2000-2009 84
Figure 67: Clinical Trial Recruitment in CNS, Depression, Prevalence Population, Brazil, (Million), 2010-2017 85
Figure 68: Clinical Trial Recruitment in CNS, Depression, Prevalence Population, India, (Million), 2010-2017 86
Figure 69: Clinical Trial Recruitment in CNS, Depression, Prevalence Population, China, (Million), 2010-2017 87
Figure 70: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Phase, 2000-2009 88
Figure 71: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Major Sponsors, 2000-2009 89
Figure 72: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited by Geography, (%), 2000-2009 90
Figure 73: Clinical Trial Recruitment in CNS, Depression, Total Number of Patients Recruited per Year, 2000-2009 91
Figure 74: Clinical Trial Recruitment in CNS, Depression, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009 92
Figure 75: Clinical Trial Recruitment in CNS, Depression, Average Number of Patients Recruited per Trial per Year, 2000-2009 93